Align Technology stock suffered a devastating blow, crashing more than 35% in a single trading day following its quarterly earnings report. The Invisalign manufacturer fell short of analyst expectations with adjusted earnings of $2.49 per share against projected $2.57, while revenue declined 1.6% year-over-year to $1.01 billion, missing consensus estimates of $1.06 billion. The company’s core business segment of clear aligners experienced a concerning 3.3% revenue drop to $804.6 million, though its imaging systems division showed modest growth of 5.6% to $207.8 million. Operating margins also contracted, falling one percentage point to 21.3% on an adjusted basis.
Outlook Triggers Investor Exodus
The dramatic sell-off was primarily driven by management’s bleak forecast for the coming quarter, projecting revenue between $965-985 million—approximately $60 million below analyst expectations. CEO leadership attributed this shortfall to inconsistent patient conversion rates, reduced treatment volumes in North America and Europe, tariff complications, and less favorable financing options for orthodontic treatments. The company announced restructuring measures expected to cost $150-170 million in the second half of 2025, while forecasting minimal growth for the full year. Despite the orthodontic industry experiencing its fourth consecutive year of decline, the long-term potential remains significant with over 600 million prospective patients globally.
Ad
Align Stock: Buy or Sell?! New Align Analysis from November 10 delivers the answer:
The latest Align figures speak for themselves: Urgent action needed for Align investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 10.
Align: Buy or sell? Read more here...
